Tuesday, September 24, 2019
- 1:45pm-3:15pm
-
Depression, Anxiety and Sleep Disturbances in Patients with Craniocervical Dystonias
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Descriptive Presentation of MRI Findings in Multiple Sclerosis Patients with Tonic Spasm
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Detection of impaired finger dexterity by objective keyboard typing test in Parkinson’s Disease: A feasibility study
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Development and Validation of the Parkinson’s Disease Medication Adherence Scale (PD- MAS)
Rating Scales · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.
Rating Scales · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Development of a questionnaire to assess sensory trick in patients with dystonia
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers
Tics/Tourette · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Differences in botulinum toxin long-term treated and non-treated cervical dystonia patients in somatosensory task-related functional imaging response.
Dystonia · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 69
- Next Page»